Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [916]
News [3751]
Articles [25]
Editorials [1]
Conferences [142]
elearning [0]
Comment: PARP inhibitor olaparib plus bevacizumab in women with ovarian cancer
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Comment: PARP inhibitor olaparib plus bevacizumab in women with ovarian cancer ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
28 Sep 2019
Comment: Immunotherapy combination for advanced NSCLC
Dr Marina Garassino - National Tumour Institute, Milan, Italy
Comment: Immunotherapy combination for advanced NSCLC ( Dr Marina Garassino - National Tumour Institute, Milan, Italy )
28 Sep 2019
Iberdomide in combination with dexamethasone for multiple myeloma
Prof Sagar Lonial - Winship Cancer Institute, Atlanta, USA
Iberdomide in combination with dexamethasone for multiple myeloma ( Prof Sagar Lonial - Winship Cancer Institute, Atlanta, USA )
25 Sep 2019
What is the role of autologous stem cell transplant in multiple myeloma?
Prof David Siegel - John Theurer Cancer Center at Hackensack University Medical...
What is the role of autologous stem cell transplant in multiple myeloma? ( Prof David Siegel - John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, USA )
25 Sep 2019
BCMA: A new biomarker for multiple myeloma
Dr James Berenson - Oncotherapeutics, West Hollywood, USA
BCMA: A new biomarker for multiple myeloma ( Dr James Berenson - Oncotherapeutics, West Hollywood, USA )
25 Sep 2019
Cancer control in Africa - Special Issue
Prof Twalib Ngoma - Muhimbili University of Health and Allied Sciences, Dar es...
Cancer control in Africa - Special Issue ( Prof Twalib Ngoma - Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania )
25 Jul 2019
Efficient in vitro screening for drug combinations: The TEVA model
Dr Angel Porgador - Ben-Gurion University of the Negev, Beersheeba, Israel
Efficient in vitro screening for drug combinations: The TEVA model ( Dr Angel Porgador - Ben-Gurion University of the Negev, Beersheeba, Israel )
10 Jul 2019
A precision medicine approach to therapeutic resistance using KEAP1 somatic...
Dr Gerald Batist - McGill University - Segal Cancer Centre, Montreal, Canada
A precision medicine approach to therapeutic resistance using KEAP1 somatic mutations ( Dr Gerald Batist - McGill University - Segal Cancer Centre, Montreal, Canada )
10 Jul 2019
Rewriting the code of life: CRISPR-Cas9 genome editing
Prof Jennifer Doudna - University of Berkeley, Berkeley, USA
Rewriting the code of life: CRISPR-Cas9 genome editing ( Prof Jennifer Doudna - University of Berkeley, Berkeley, USA )
10 Jul 2019
Chemotherapy-free strategies in treating leukaemia
Prof Robin Foa - University of Rome, Rome, Italy
Chemotherapy-free strategies in treating leukaemia ( Prof Robin Foa - University of Rome, Rome, Italy )
20 Jun 2019
ADMIRAL trial results: Gilteritinib versus salvage chemotherapy in patients...
Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA
ADMIRAL trial results: Gilteritinib versus salvage chemotherapy in patients with FLT3-mutated relapsed/refractory AML ( Prof Alexander Perl - University of Pennsylvania, Philadelphia, USA )
20 Jun 2019
Multiple myeloma science from EHA 2019
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
Multiple myeloma science from EHA 2019 ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )
20 Jun 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation